Question

Difficulty: HardInfectious Disease Mechanisms

A 34-year-old man who actively injects black tar heroin is brought to the emergency department by his friends due to progressive difficulty opening his mouth, sweating, and severe muscle spasms in his back. He has not received any preventative medical care or vaccinations in over two decades. Physical examination reveals diaphoresis, a fixed facial smile, and pronounced arching of the back. A necrotic, purulent ulcer is noted on his left forearm. The causative pathogen produces a potent neurotoxin responsible for his clinical presentation. Arrange the following steps in the pathophysiological cascade of this toxin's mechanism of action in the correct chronological sequence, from initial host interaction to the ultimate physiologic effect.

  1. 1Binding of the toxin to polysialogangliosides on the presynaptic membrane of local lower motor neurons
  2. 2Internalization and retrograde axonal transport of the toxin toward the cell body in the spinal cord
  3. 3Trans-synaptic movement of the toxin into presynaptic inhibitory interneurons
  4. 4Zinc-dependent endopeptidase cleavage of the SNARE protein synaptobrevin
  5. 5Inhibition of vesicular fusion and blockade of gamma-aminobutyric acid (GABA) and glycine release
  6. 6Unrestrained alpha motor neuron excitation resulting in sustained, severe muscle contractions

Answer

The correct sequence is: 1) Binding to polysialogangliosides on the motor nerve terminal, 2) Retrograde axonal transport to the spinal cord, 3) Trans-synaptic movement into inhibitory interneurons, 4) Cleavage of the SNARE protein synaptobrevin, 5) Inhibition of GABA and glycine release, and 6) Unrestrained alpha motor neuron excitation.
The pathogenesis of tetanus begins when Clostridium tetani produces tetanospasmin, which initially binds to peripheral motor neuron terminals. It is then transported retrogradely to the central nervous system, where it crosses trans-synaptically into inhibitory interneurons. Within these interneurons, the toxin's light chain acts as a zinc endopeptidase to cleave synaptobrevin, a vital SNARE protein. This prevents the vesicular fusion and subsequent release of the inhibitory neurotransmitters GABA and glycine. The resulting loss of central inhibition leads to uninhibited motor neuron firing and the characteristic spastic paralysis.

Step-by-Step Solution

1
Identify the clinical syndrome and causative pathogen.
The patient's trismus (lockjaw), risus sardonicus (fixed smile), and opisthotonus (arching of the back), combined with a history of unvaccinated injection drug use, indicate tetanus caused by Clostridium tetani.
Establishing the correct diagnosis is required to determine which pathogen's molecular mechanism is being tested.
2
Determine the initial site of toxin entry.
Tetanospasmin first binds to polysialogangliosides on peripheral lower motor neurons.
The toxin is produced in the anaerobic wound and must enter the nervous system locally.
3
Trace the toxin's path to its target site.
The toxin undergoes retrograde axonal transport to the central nervous system.
Unlike botulinum toxin, tetanospasmin does not primarily act at the peripheral neuromuscular junction; it must reach the spinal cord to exert its characteristic clinical effects.
4
Identify the cellular transfer within the CNS.
The toxin moves trans-synaptically from the motor neuron into presynaptic inhibitory interneurons (Renshaw cells).
The toxin's ultimate targets are the cells responsible for inhibiting motor neurons.
5
Delineate the molecular mechanism of action.
Inside the interneuron, the toxin's zinc-endopeptidase light chain cleaves the SNARE protein synaptobrevin (VAMP).
Cleavage of this protein disrupts the vesicle fusion machinery.
6
Determine the final physiological consequence.
Cleavage of synaptobrevin blocks the release of GABA and glycine, leading to unrestrained alpha motor neuron excitation and spastic paralysis.
Loss of central inhibition causes the severe muscle spasms seen clinically.

Key Concept

Tetanus Toxin (Tetanospasmin) Pathogenesis
Rate this question